Exploring the Types of Wearables Used in Modern Clinical Research

Introduction: The Rise of Wearables in Clinical Trials

Wearable technology has revolutionized modern clinical trials, offering continuous, real-time patient data capture in natural environments. Unlike traditional site visits, wearable devices empower decentralized, patient-centric models that enhance data quality and reduce burden on subjects. From tracking ECGs to detecting sleep disorders, wearables are becoming pivotal in clinical study design and execution.

As per recent FDA guidelines and GxP expectations, wearables used in clinical trials must meet strict validation, calibration, and data integrity standards. This tutorial dives deep into the various categories of wearables commonly adopted in trials, their technical capabilities, and case studies from real-world implementation.

1. Smartwatches and Fitness Bands

Smartwatches like the Apple Watch and Fitbit are widely used in Phase II and III trials to collect continuous data such as:

• ✅ Heart rate variability (HRV)
• ✅ Step count and activity level
• ✅ Sleep duration and quality
• ✅ ECG recordings in newer models (FDA-cleared)

These devices are especially valuable in trials targeting cardiovascular, metabolic, and psychiatric conditions. Their high user acceptance and Bluetooth integration with mobile apps facilitate seamless data transmission to trial platforms.

Example: In a post-marketing observational study, a leading sponsor used Garmin Vivosmart 4 to assess baseline mobility changes in patients with multiple sclerosis over 6 months. Data was linked directly to their validated ePRO platform.

2. Continuous Glucose Monitors (CGMs)

CGMs such as Dexcom G6 or Abbott’s FreeStyle Libre are highly adopted in diabetes trials. These sensors provide interstitial glucose readings every 5–15 minutes, aiding real-time glycemic control analysis. Benefits include:

• ✅ 24/7 monitoring without finger pricks
• ✅ High patient compliance
• ✅ Granular data on glucose excursions

They are especially useful in crossover trials, adaptive studies, and pediatric populations. CGM data often integrates with mobile apps, enabling real-time alerts for hypoglycemia events.

3. Wearable ECG and Heart Rate Monitors

Clinical-grade ECG patches and monitors such as Zio Patch (iRhythm), Biostrap, or BioBeat are used in cardiac safety and arrhythmia detection studies. These provide:

• ✅ Single or multi-lead ECG
• ✅ Continuous heart rhythm tracking
• ✅ Early detection of QT prolongation or AFib

Such devices are often mandated by sponsors in oncology and CNS trials, where investigational products carry cardiotoxicity risk.

4. Smart Patches and Biosensors

Wearable biosensors include smart patches like VitalPatch (PhysIQ), TempTraq, and MC10 BioStamp. These single-use or reusable sensors adhere to the body and monitor multiple vitals:

• ✅ Skin temperature
• ✅ Respiratory rate
• ✅ Motion or fall detection
• ✅ Posture and activity level

They are frequently used in inpatient studies, oncology trials, and studies involving elderly or high-risk patients. Their passive operation ensures low disruption and high compliance.

5. Pulmonary and Spirometry Wearables

Wearable spirometers like ResApp, NuvoAir, or Microlife devices allow real-time measurement of lung functions such as:

• ✅ FEV1, FVC, PEF parameters
• ✅ Wheeze and cough analysis
• ✅ Nocturnal respiration pattern

These are highly useful in COPD, asthma, and COVID-related research studies. Many are integrated with AI to assist in early diagnosis or endpoint confirmation.

6. Sleep Trackers and Smart Clothing

Advanced devices like Oura Ring, Withings Sleep Analyzer, or Dreem 2 headbands measure:

• ✅ Sleep stages (REM, light, deep)
• ✅ Breathing interruptions
• ✅ HR during sleep cycles

Smart clothing embedded with biosensors (e.g., Hexoskin, Sensoria) collect real-time metrics like respiratory expansion, posture, and ECG in athletes or bedridden patients. Their potential in neurological or fatigue monitoring trials is still under early evaluation.

7. Considerations for GxP Compliance and Validation

All wearable devices in clinical trials must adhere to GxP expectations and undergo thorough validation:

• ✅ Installation Qualification (IQ)
• ✅ Operational Qualification (OQ)
• ✅ Performance Qualification (PQ)
• ✅ FDA 21 CFR Part 11 compatibility for data handling

Also, any device collecting personal data must comply with HIPAA, GDPR, and local DPP (Data Privacy Protection) acts. Auditable logs, backup, and cybersecurity are critical aspects evaluated by QA auditors.

8. Challenges and Real-World Examples

While promising, wearables pose several challenges in trial environments:

• ⚠️ Data Overload: High-frequency data needs robust storage and analytics systems
• ⚠️ Protocol Deviations: Patient non-use or improper wear may skew results
• ⚠️ Connectivity Gaps: Remote sites or rural regions may lack app integration or internet bandwidth

Case Study: A global Phase III insomnia study integrated the Dreem headband for sleep tracking. Though endpoints were achieved, 15% of subjects dropped out due to app syncing issues, highlighting the need for user-centric UI design and field support.

Conclusion

From smartwatches to biosensors and AI-enabled trackers, wearables are redefining data collection in clinical research. Their integration allows for greater decentralization, improved subject experience, and high-fidelity data. However, sponsors must ensure regulatory compliance, robust SOPs, and end-user training to unlock their full potential.

References:

• ICH E6(R3) Draft Guideline on Good Clinical Practice
• PharmaGMP: GMP Case Studies on Blockchain

How to Select the Most Suitable Wearables for Your Clinical Study

Why Wearable Device Selection is Critical in Trial Design

Selecting the right wearable devices for a clinical trial is more than a procurement decision—it’s a regulatory, operational, and scientific one. Each study’s endpoints, population, duration, and geographic scope influence the choice of wearable technology. Devices that are not fit-for-purpose can lead to poor compliance, low data quality, and regulatory rejections.

For example, using a wrist-based optical sensor to measure blood oxygen saturation (SpO2) may not yield accurate results in elderly or cardiac patients, where peripheral perfusion is low. This could compromise endpoint validity. Regulatory authorities like the FDA and EMA expect sponsors to justify their choice of wearable, supported by validation and performance data.

According to a review published by PharmaGMP, nearly 35% of wearable-related protocol deviations in decentralized trials stem from misalignment between device capabilities and endpoint requirements.

Key Criteria for Evaluating Wearable Devices

Sponsors should evaluate wearable options based on both scientific and operational parameters. The following criteria are commonly used:

• Endpoint Alignment: Is the device validated to measure the required primary or secondary endpoint?
• Population Suitability: Is the device ergonomic and usable for the study population (e.g., pediatric, geriatric)?
• Data Integrity: Does the device maintain ALCOA+ standards?
• Battery Life and Storage: Can it operate uninterrupted for at least 24-72 hours?
• Connectivity: Can it sync with mobile devices or Wi-Fi for real-time data upload?
• Regulatory Status: Has the device received 510(k), CE mark, or local regulatory clearance?

The following dummy table illustrates how wearable devices can be scored across critical attributes:

Study-Specific Factors Influencing Wearable Choice

No single wearable is suitable for all studies. Several variables must be considered during feasibility assessment:

• Study Duration: Long-term studies need durable devices with strong battery life and user support mechanisms.
• Decentralized vs On-Site: Remote trials require more autonomous wearable devices with self-sync capabilities.
• Geography: Device connectivity and regulatory approvals vary by country.
• Site Support Capacity: If sites lack IT support, avoid complex setups requiring firmware updates.

A cardiovascular trial conducted across 12 countries faced sync issues in rural regions due to lack of 4G connectivity. Switching to a wearable with offline storage and delayed sync capability resolved 80% of data gaps, as shared by ClinicalStudies.in.

Vendor Qualification and Technical Due Diligence

Selecting the right wearable involves more than product specs—it requires vendor evaluation. Sponsors should audit the wearable vendor’s:

• Software Development Lifecycle (SDLC)
• Data Privacy and Security Framework (e.g., GDPR, HIPAA)
• Technical Support SLAs and Uptime Guarantees
• Firmware Version Control and Update Policies
• Integration Capabilities with EDC or CTMS systems

Conduct a vendor qualification questionnaire and request validation packages, including performance testing, calibration protocols, and historical deviations.

Also ensure the vendor provides APIs with thorough documentation. This is crucial if integration with sponsor data platforms is required. Sponsors may also request a sandbox environment to test integrations during feasibility.

Developing a Wearable Selection SOP

Standardizing the wearable selection process improves consistency across studies and enhances audit readiness. An internal SOP for wearable evaluation should include:

• Device feasibility checklist and scoring criteria
• Cross-functional review process (clinops, IT, regulatory, QA)
• Fit-for-purpose justification template
• Vendor audit and qualification checklist
• Documentation for change control in device selection

For example, in a CNS trial involving elderly patients, a sponsor used a wearable with minimal screen glare and tactile buttons after SOP-driven usability testing. This improved compliance by 22% over the first 30 days.

Best Practices for Operational Deployment of Selected Devices

Once a device is selected, implementation planning begins. The following practices help ensure smooth deployment:

• Provide trial-specific user manuals with annotated screenshots
• Include device usage training during SIV and site startup
• Set up a central tech support line (with regional escalation)
• Prepare backup devices at each site or with courier access
• Monitor device compliance and sync rates weekly

Include wearable deployment KPIs in your clinical quality dashboard. For decentralized trials, consider remote device monitoring capabilities to check signal strength, battery level, and sync status.

According to ICH E6(R3), centralized monitoring and real-time data oversight are key components of modern risk-based quality management systems.

Conclusion: Strategic Selection for Better Outcomes

Choosing the right wearable device is a foundational step toward a successful, compliant, and efficient clinical trial. It requires aligning study needs with technical capabilities, regulatory expectations, and patient usability. A structured, SOP-driven selection and deployment process ensures wearables enhance—rather than complicate—your study.

As wearable technology evolves, proactive vendor engagement, robust testing, and real-world feedback loops will remain essential for pharma and CRO professionals aiming to run trials at the intersection of science and innovation.